Stories by Max Kozlov

Researchers in the U.S. are grappling with Trump administration executive orders around health and science agency funding and communications.

The U.S. National Science Foundation has unfrozen grant funding, but it continues to scrutinize research projects, sowing turmoil

President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health and appears to have erased diversity programming pages at the agency’s website

After his second inauguration, President Donald Trump signed a host of executive orders, some with important implications for science

Sweeping reorganization and more research scrutiny could be on the way for the U.S. National Institutes of Health

Analysis of a strain of the virus circulating in Central Africa shows genetic mutations indicative of sustained human-to-human spread

As the daughter of a cancer researcher, Kamala Harris would bring a lifelong familiarity with science to the presidency, experts say

Congressional representatives grilled Anthony Fauci, former head of the U.S. National Institute of Allergy and Infectious Diseases, about the government’s early response to the COVID pandemic

A small South Pacific fern boasts more than 50 times as many base pairs as the human genome

Nerve cells form long-term memories with the help of an inflammatory response

People who had tiny plastic particles lodged in a key blood vessel were more likely to experience serious health problems or die during a three-year study

U.S. regulators will consider clinical trials of a system that mimics the womb, which could reduce deaths and disability for babies born extremely preterm

Some scientists say the U.S. Food and Drug Administration’s suggestion of updating COVID vaccines each year, as happens with influenza vaccines, could boost uptake. But others are less convinced

Public health leader Anthony Fauci advises early-career researchers “not to be deterred” by vitriol

Controversy surrounding a study that involved modifying SARS-CoV-2, the virus that causes COVID, has prompted researchers to call for better guidance from funders

Thousands of tumor samples provide the clearest link yet between cancer and fungi, but more research is needed

The antiviral Tecovirimat (TPOXX) shows promise against monkeypox, but human data and supplies are limited

From the AIDS epidemic to the COVID-19 pandemic, the iconic medical chief has advised seven presidents on numerous outbreaks

Researchers are racing to understand the latest monkeypox outbreaks—from their origins to whether they can be contained

Researchers hope they could one day be used as a routine clinical tool by physicians.

The U.S. Department of Justice announced major changes to the espionage-protection program, but scientists hope for further acknowledgment of the damage done

After long delay, U.S. President Joe Biden picks Robert Califf to once again head the U.S. Food and Drug Administration

Immune cells might abort SARS-CoV-2 infection, forestalling a positive PCR or antibody test, a study in hospital workers suggests

Synapse genes help cells to communicate in a sponge’s digestive chambers